SCHEMBL7581836

SCHEMBL7581836

COCCC(COC)n1nnc2c(Nc3c(C)cc(C)cc3Cl)nc(C)cc21

nearest known ligand 0.89

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.89
LCK P06239 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474139 1.00 CRHR1 (0.89) CRHR1LCK
SCHEMBL16606730 0.94 CRHR1 (1.00) CRHR1LCK
SCHEMBL27516758 0.82 CRHR1 (0.71) CRHR1LCK
SCHEMBL7217257 0.79 CRHR1 (0.54) CRHR1
SCHEMBL7217253 0.79 CRHR1 (0.54) CRHR1
SCHEMBL5866990 0.77 CRHR1 (0.66) CRHR1
SCHEMBL7472645 0.73 CRHR1 (0.65) CRHR1
SCHEMBL7472647 0.73 CRHR1 (0.65) CRHR1
SCHEMBL7504068 0.72 CRHR1 (0.59) CRHR1
SCHEMBL7626666 0.71 CRHR1 (0.56) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP claimed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP claimed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO claimed
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed